
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review; check the urgency of imaging for new focal symptoms, the steroid dose and taper, the decision against seizure prophylaxis, the WHO CNS5 integrated diagnosis, the Stupp protocol doses and monitoring, the tumor-treating fields discussion, the RANO 2.0 reading of the first post-treatment MRI, and the fall plan for a polio survivor. | ||
| provenance review | not_started | Recent-death rule: only what she made public, what was reported during her life, and obituaries and reference accounts: the National Women's History Museum, the U.S. Olympic & Paralympic Museum, the Tennessee Encyclopedia, Women in World History, Olympedia and the Deseret News obituary. The type and treatment of her brain cancer were never made public; everything clinical is synthetic. | ||
| safe messaging review | not_started | No mental health or substance claim is made; mood screens are synthetic and below the threshold for a safety assessment. Her death is recorded once, without detail. No relative is named in the modern episode, and no health fact or decision is attributed to any real person. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-09-14 Progress note 04 (C-CDA) | Blood count in week 6 of concurrent treatment | Weekly during concurrent temozolomide | A deviation: not drawn in the last week of radiotherapy because the clinic's standing order was set for the Monday, a holiday that week, and was not moved. No harm resulted: today's count, a week later, shows platelets 112 and neutrophils 2.4, above the levels that would have stopped temozolomide, and she had no bleeding or fever. Corrective action: today's count; future standing orders are tied to treatment days, not a weekday |
| 2026-10-09 Progress note 05 (C-CDA) | Liver tests midway through adjuvant cycle 1 | Midway through the first cycle | A planned deviation: to spare her an extra trip, the mid-cycle liver tests will be drawn with the day-22 blood count, about a week after the label's midpoint. Today's liver tests are normal after a grade 1 rise. Outcome and action to be recorded at that draw |
| Visit | Type | Item | Status | Detail |
|---|---|---|---|---|
| 2026-07-02 Progress note 02 (C-CDA) | Imaging | Functional MRI with tractography | Ordered | In four days |
| 2026-07-29 Progress note 03 (C-CDA) | Laboratory | Hepatitis B, hepatitis C and HIV screening | Ordered | Drawn today |
| 2026-07-29 Progress note 03 (C-CDA) | Medication safety | Pneumocystis pneumonia prophylaxis | Ordered | Sulfamethoxazole-trimethoprim three times a week from the first day |
| 2026-07-29 Progress note 03 (C-CDA) | Medication safety | Antiemetic before temozolomide | Ordered | Ondansetron 30 to 60 minutes before the bedtime dose, on an empty stomach |
| 2026-09-14 Progress note 04 (C-CDA) | Imaging | MRI of the brain after chemoradiation | Ordered | In about three weeks; enhancement in the first three months may be treatment effect (pseudoprogression) and is read by RANO 2.0 |
| 2026-09-14 Progress note 04 (C-CDA) | Referral | Palliative care | Referred | Outpatient consultation booked in two weeks |
None.
None.
None.
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-07-02 | White cell count | 11.8 10*3/uL (high) | High |
| 2026-07-02 | Glucose | 138 mg/dL (high) | High |
| 2026-07-29 | Glucose | 168 mg/dL (high) | High |
| 2026-09-14 | Hemoglobin | 11.9 g/dL (low) | Low |
| 2026-09-14 | White cell count | 3.6 10*3/uL (low) | Low |
| 2026-09-14 | Absolute lymphocyte count | 0.5 10*3/uL (low) | Low |
| 2026-09-14 | Platelets | 112 10*3/uL (low) | Low |
| 2026-09-14 | ALT | 48 U/L (high) | High |
| 2026-09-14 | AST | 39 U/L (high) | High |
| 2026-10-09 | Absolute lymphocyte count | 0.6 10*3/uL (low) | Low |
| 2026-10-29 | Hemoglobin | 11.8 g/dL (low) | Low |
| 2026-10-29 | White cell count | 3.4 10*3/uL (low) | Low |
| 2026-10-29 | Absolute lymphocyte count | 0.6 10*3/uL (low) | Low |
| 2026-10-29 | Platelets | 121 10*3/uL (low) | Low |